Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of escitalopram orally dispersible tablet versus immediate-release tablet in healthy men
NL-OMON32586Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of escitalopram in major depressive disorder (MDD) and anxiety disorder (2 arms), sponsored by Lundbeck. Primary endpoints: AUC and Cmax. Started Jan 2010; status: active, not recruiting.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NL-OMON32586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32586.